Effects of ApoE in the Panama aging research initiative: A community‐dwelling older adults’ cohort in Panama

Abstract

AbstractBackgroundThe Panama Aging Research Initiative (PARI) is a longitudinal study of more than 800 adults aged 60 years and older. The objective of this analysis consists of identifying the effects of Apolipoprotein E (ApoE) gene as a risk factor for sporadic Alzheimer’s disease (AD), with elevated risk for ε4‐carriers and reduced risk for ε2‐carriers.MethodOur ongoing community‐based cohort (n = 400) has undergone clinical interviews, neuropsychological testing, and assessments of frailty at two time points (14‐29 months apart). Fasting blood draws were obtained for measurements of genetic and blood‐based biological markers. DNA was extracted from whole blood and (ApoE) genotyping (n = 330) was conducted according to standardized PCR procedures. We will examine whether ε2 and ε4 are associated with differential rates of normal cognitive aging, and whether associations of ε4 with cognitive decline are modified by sex, education or other health conditions common among older adults in Panama, including chronic illnesses, polypharmacy and frailty.ResultOur study evaluate whether ApoE ε2, ε3 and ε4 allele frequency is a significant factor associated with cognition and daily function in elderly individuals. Specifically, we focus on evaluating the frequency of ApoE ε4 expression as a risk for cognitive impairment. Together these results contribute to our understanding of the risk factors of cognitive outcomes among Hispanic populations outside the US.ConclusionLittle is known about the factors associated to cognitive health at old age in Central American populations. Genetic biomarkers could be used as a tool for diagnostic testing. It is expected that ApoE‐ε4 polymorphism will correlate with cognitive deficit among the elderly population and those at risk for cognitive impairment.